Artes Medical introduces Elevess™, an FDA-approved hyaluronic acid (HA) based dermal filler formulated with an anesthetic for the treatment of facial wrinkles, such as nasolabial folds.
“The market launch and commercial sale of Elevess marks an important milestone for both Artes Medical and the aesthetic injectable marketplace. We believe physicians and their patients will welcome a new choice in wrinkle fillers—one that is as comfortable and affordable as it is effective,” says Christopher J. Reinhard, executive chairman of Artes Medical. “By adding Elevess to their treatment arsenals, physicians can offer cost-effective wrinkle correction to more patients than ever before. Elevess may also help physicians build a funnel that moves patients towards a longer-lasting option like ArteFill, the first FDA-approved non-resorbable wrinkle filler. Together, these benefits make Elevess ‘The Feel Good Filler’™ for physicians and patients alike, and Artes Medical is pleased to bring this new product to market just weeks after the announcement of our distribution agreement with Anika Therapeutics.”
According to the company, in a randomized, controlled pivotal study of 208 patients, Elevess was shown to be safe and effective for up to 6 months.
[Business Wire, August 5, 2008]